The department of defense pharmacy benefit management program

Military Medicine

Volumn 170, Issue 4, 2005, Pages 302-304

  Ridderhoff, Kevin ^a   Remund, Daniel ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR FORCE; ARMY; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; DRUG INDUSTRY; HUMAN; MILITARY MEDICINE; NAVY; PERSONNEL MANAGEMENT; PHARMACY; PHARMACY BENEFIT MANAGER; PRACTICE GUIDELINE; PRESCRIPTION; UNITED STATES;

EID: 17444370509     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.170.4.302     Document Type: Article

References (23)

1. Bae J, Justice P: Pharmacy benefit management contracting: an assessment from a recent public sector procurement experience. J Health Care Finance 2002; 29: 49-56.
2. Render M, Nowak J, Hammond E, Roselle G: Methods for estimating and comparing VA outpatient drug benefits with the private sector. Med Care 2003; 41(Suppl):II61-9.
3. U.S. General Accounting Office: Defense Health Care: Fully Integrated Pharmacy System Would Improve Service and Cost-Effectiveness. Report GAO/HEHS-98-176. Washington, DC, U.S. General Accounting Office, June 12, 1998.
4. Kongstvedt P: The Managed Health Care Handbook, Ed 4, pp 413-50. Gaithersburg, MD, Aspen Publishing, 2001.
5. Shi S, Singh D: Delivering Health Care in America: A Systems Approach, Ed 2. pp 1-31. Gaithersburg, MD, Aspen Publishing, 2001.
6. Murray M, Deardorff F: Does managed care fuel pharmaceutical industry growth? PharmacoEconomics 1988; 14: 341-8.
7. Mullins C, Wang J: Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making. PharmacoEconomics 2002; 20: 9-21.
8. Olson B: Approaches to pharmacy benefit management and the impact of consumer cost sharing. Clin Ther 2003; 25: 250-72.
9. Taylor J, Jacobs M: The tough decisions that no one wants to make. Benefits Q 2003; 19: 19-29.
10. Department of Defense PharmacoEconomic Center: A TMA/PEC Update 2003. San Antonio. TX, Department of Defense PharmacoEconomic Center. 2004.
11. Department of Defense PharmacoEconomic Center: Home page. February 2004. Available at http://www.pec.ha.osd.mil/mission.htm: accessed February 9, 2004.
12. Finder S: Providing cost-effective therapy using pharmacoeconomic evaluations: the public sector approach. Clin Ther 1997; 19: 160-6.
13. Williams R, Moran E, Bottaro S, et al: Pharmaceutical services in the United States Army. Am J Health Syst Pharm 1997; 54: 773-8.
14. Department of Defense PharmacoEconomic Center: Estimated Cost Avoidance in DoD MTFs Due to National Pharmaceutical Contracts. Fiscal Years 1999-2002 (Fact Sheet). San Antonio, TX. Department of Defense PharmacoEconomic Center, 2004.
15. Corrigan G: Pharmacy Data Transaction Service boosts TRICARE's delivery capabilities by harnessing technology. Available at http://www.mmt-kmi.com/ archives.cfm; accessed February 9, 2004.
16. TRICARE/Military Health System: Pharmacy Data Transaction Service will increase safety, services. September 28, 2000. Available at http://www.tricare. osd.mil/news/2000/news2000_17.htm; accessed February 9, 2004.
17. Haag S, Cummings M, McCubbrey D: Management Information Systems for the Information Age, Ed 4, pp 2-69. New York, NY. McGraw-Hill, 2004.
18. Department of Defense PharmacoEconomic Center: PDTS Factoids thru 31 December 2003 (Fact Sheet). San Antonio, TX, Department of Defense PharmacoEconomic Center, 2004.
19. TRICARE/Military Health System: TRICARE pharmacy copays. April 1, 2001. Available at http://www.tricare.osd.mil/pharmacy/newcopay.cfm: accessed February 9, 2004.
20. Giaquinta D: Defined-contribution products and their influence on pharmacy benefit management. Manag Care Interface 2003; 16: 36-8.
21. Nair K, Wolfe P, Valuck R, McCollum M, Ganther J, Lewis S: Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. J Manag Care Pharm 2003; 9: 123-33.
22. Kleinke J: The price of progress: prescription drugs in the health care market. Health Aff 2001; 20: 43-60.
23. Rumbaugh J: Department of Defense medical transformation: a case for the defense health agency. Milit Med 2003; 168: 626-30.